These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 35563313)

  • 21. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
    Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
    Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
    Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
    Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines.
    Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA
    Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-8/CXCR2 mediates tropism of human bone marrow-derived mesenchymal stem cells toward CD133
    Ma X; Chen J; Liu J; Xu B; Liang X; Yang X; Feng Y; Liang X; Liu J
    J Cell Physiol; 2021 Apr; 236(4):3114-3128. PubMed ID: 33078417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic Characteristics of Dormant Human Non-Small Cell Lung Cancer Cells Surviving Multifraction X-Ray Irradiation.
    Pustovalova MV; Yashkina EI; Alhaddad L; Osipov AN; Chen Y; Leonov SV
    Bull Exp Biol Med; 2022 Nov; 174(1):76-80. PubMed ID: 36437335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
    Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotheranostic Targeting Cancer Stem Cells in Human Colorectal Cancer Xenografts.
    She X; Qin S; Jing B; Jin X; Sun X; Lan X; An R
    Mol Imaging Biol; 2020 Aug; 22(4):1043-1053. PubMed ID: 32125599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
    PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-ray irradiation altered chemosensitivity of a p53-null non-small cell lung cancer cell line.
    Tsutsumi K; Yasuda M; Nishioka T
    Cell Struct Funct; 2006; 31(2):47-52. PubMed ID: 16951535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Stemness' and 'senescence' related escape pathways are dose dependent in lung cancer cells surviving post irradiation.
    Tsolou A; Lamprou I; Fortosi AO; Liousia M; Giatromanolaki A; Koukourakis MI
    Life Sci; 2019 Sep; 232():116562. PubMed ID: 31201845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro characterization of CD133
    Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
    BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure.
    Tsunekuni K; Konno M; Haraguchi N; Koseki J; Asai A; Matsuoka K; Kobunai T; Takechi T; Doki Y; Mori M; Ishii H
    Sci Rep; 2019 Oct; 9(1):14861. PubMed ID: 31619711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
    Wang R; Dong HX; Zeng J; Pan J; Jin XY
    J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
    Sahlberg SH; Spiegelberg D; Glimelius B; Stenerlöw B; Nestor M
    PLoS One; 2014; 9(4):e94621. PubMed ID: 24760019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in CD133
    Fang LZ; Zhang JQ; Liu L; Fu WP; Shu JK; Feng JG; Liang X
    Oncol Res; 2017 May; 25(5):819-829. PubMed ID: 27983936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44
    Kim J; Choi KW; Lee J; Lee J; Lee S; Sun R; Kim J
    Int J Biol Sci; 2021; 17(7):1644-1659. PubMed ID: 33994850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.